ArticleCureus2024
Metachronous Cutaneous Melanoma Metastases of the Left Anterior Paranasal Sinuses and the Right Nasopharynx That Were Treated Surgically: A Case Report With Literature Review.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastases of cutaneous melanoma to the paranasal sinuses and nasopharynx are considered rare. We reported the case of a patient with cutaneous melanoma metastasizing to the left anterior infundibulum and seven months later to the right nasopharynx that was successfully treated by endonasal endoscopic surgery as a single treatment modality. No adjuvant radiotherapy was performed. We described all known cases of metastatic cutaneous melanomas to the paranasal sinuses and nasopharynx. In cases of neither lung involvement nor open foramen ovale, the metastatic route might be the vertebral venous system. The histopathologic differentiation between primary mucosal and metastatic cutaneous melanoma remains critical. Adequate surgical treatment is crucial. More data are needed to further understand the role of adjuvant radiotherapy. Molecular markers, such as KIT and BRAF mutations, should be examined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.